简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-09-14 10:53 Ahead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity
2023-09-13 10:11 ReNAgade Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
2023-09-13 09:54 KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
2023-09-12 09:53 Monrol Announces Investment to Expand its n.c.a. Lu-177 Production Capacity
2023-09-12 09:34 SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
2023-09-11 18:58 Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis
2023-09-08 18:11 Morinaga Milk's Probiotic Bifidobacterium longum subsp. longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil
2023-09-08 08:26 Biocytogen Enters into Antibody Evaluation, Option and License Agreement with Myricx for ADC Development
2023-09-06 15:14 Organon Bolsters Research & Development Expertise with Two Leadership Appointments
2023-09-06 13:41 Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
2023-09-05 13:55 Berkshire Hathaway Specialty Insurance Promotes Edwin Sim to Lead Executive & Professional Lines in Singapore
2023-09-02 12:48 Dust Control Solutions Using Spray Nozzles from IKEUCHI
2023-09-02 12:40 J-HOTATE Association to Exhibit at Seafood Expo Asia to Showcase High Quality Fresh Japanese Scallops to Overseas Markets
2023-09-02 08:50 Biocytogen Establishes Two Business Divisions To Distinguish Preclinical Models and Services (BioMice) from Antibody Drug R&D
2023-08-30 09:24 Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
2023-08-29 10:13 Sinovac Announces Change of Legal Representative of Sinovac Beijing
2023-08-28 14:39 SUSMED’s DTx Approved in Japan for the Treatment of Insomnia
2023-08-25 11:52 European Medicines Agency Accepts Novaliq’s Marketing Authorization Application for CyclASol® (ciclosporin ophthalmic solution) 0.1% for the Treatment of Dry Eye Disease
2023-08-24 13:23 Royalty Pharma and Ferring Pharmaceuticals Enter into US $500 million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (nadofaragene firadenovec-vncg)
2023-08-24 10:09 Kenvue Becomes a Fully Independent Company Following Final Separation from Johnson & Johnson

Business Wire Weibo

Press Releases

Latest Releases